Point-Counterpoint: To Screen or Not To Screen for Methicillin-Resistant Staphylococcusaureus
- 1 March 2010
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (3) , 683-689
Abstract
There are few more compelling questions in clinical microbiology today than the issue of whether or not to screen for the presence of methicillin-resistant Staphylococcus aureus (MRSA), with the results being used to institute infection control interventions aimed at preventing transmission of MRSA in health care environments. Numerous different matters must be addressed when considering a screening program. Who is to be screened, what method is to be employed to detect MRSA, and what sites should be sampled? When and how often should the screening be performed? Who is going to pay for the screening, and, finally and perhaps most importantly, how are screening results to be communicated to health care providers and what kind of interventions are best undertaken based on the results? Numerous governmental agencies have mandated MRSA screening programs, and yet several authorities in infection control organizations have questioned the appropriateness of mandated screening. In this Point-Counterpoint feature, Dr. Lance Peterson of Evanston Hospital (Evanston, IL) offers his perspective on why screening for MRSA is to be encouraged. Dr. Daniel Diekema of the University of Iowa Carver College of Medicine (Iowa City, IA) offers an opposing view.Keywords
This publication has 37 references indexed in Scilit:
- Reduction in the rate of methicillin-resistant Staphylococcus aureus acquisition in surgical wards by rapid screening for colonization: a prospective, cross-over studyClinical Microbiology and Infection, 2010
- Implementation of a Universal Admission Surveillance and Decolonization Program for Methicillin-Resistant Staphylococcus aureus (MRSA) Reduces the Number of MRSA and Total Number of S. aureus Isolates Reported by the Clinical LaboratoryJournal of Clinical Microbiology, 2009
- Chromogenic Media vs Real-Time PCR for Nasal Surveillance of Methicillin-ResistantStaphylococcus aureusAmerican Journal of Clinical Pathology, 2009
- Adverse outcomes associated with contact precautions: A review of the literatureAmerican Journal of Infection Control, 2009
- Are There Better Methods of Monitoring MRSA Control than Bacteraemia Surveillance? An Observational Database StudyPLOS ONE, 2008
- The Use of Active Surveillance Cultures in Adult Intensive Care Units to Reduce Methicillin‐ResistantStaphylococcus aureus–Related Morbidity, Mortality, and Costs: A Systematic ReviewClinical Infectious Diseases, 2008
- A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐ResistantStaphylococcus aureusDisease in San Francisco, 2004–2005Clinical Infectious Diseases, 2008
- Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus : cluster randomised crossover trialBMJ, 2008
- Performance of the BD GeneOhm Methicillin-Resistant Staphylococcus aureus Test before and during High-Volume Clinical UseJournal of Clinical Microbiology, 2007
- Impact of Routine Intensive Care Unit Surveillance Cultures and Resultant Barrier Precautions on Hospital‐Wide Methicillin‐ResistantStaphylococcus aureusBacteremiaClinical Infectious Diseases, 2006